Intellia Therapeutics' innovative gene editing technology could revolutionize medicine, but investors need a strong stomach ...

CRISPR technology allows for precise DNA modifications, holding promise for treating genetic disorders and revolutionizing ...

BMO Capital analyst Kostas Biliouris maintained a Buy rating on Intellia Therapeutics (NTLA – Research Report) today and set a price ...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going ...

A collaborative effort between investigators at the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) and Massachusetts General Hospital (MGH), a founding ...

Because sickle cell disease isn’t as progressive a disease as others that have gene therapies available, there isn’t as much ...

A collaborative effort between investigators at the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) and Massachusetts General Hospital (MGH), a founding ...

A collaborative effort between investigators at the National Institutes of Health's National Institute of Allergy and ...

This diverse set of growth stocks offers tremendous opportunities in the fields of AI, space, biotech, and emerging ...

The lawsuit focuses on scientific work that helped clear the path for creating mRNA vaccines to fight the COVID-19 pandemic.

Our current food system is facing a myriad of critical challenges. The United Nations predicts that the world population will ...